Leiden University Una Europa Seed Funding

• Seed funding is available from Leiden University for researchers, lecturers, and support staff to initiate Una Europa collaborations.
• Apply for up to €15,000 in funding for projects that strengthen international ties within Una Europa.
• Examples include research visits, small-scale joint research projects, and co-publications, jointly developed or blended courses, or preparatory work for external grant applications.
• Also open to PhD candidates, early-career researchers, and professional support staff.
• Deadline: April 30.
• https://www.medewerkers.universiteitleiden.nl/onderzoek/interne-onderzoeksfinanciering/una-europa-seed-funding

Una Europa Challenge 2026: Data Science and AI for Social Welfare

• July 22–24 in Madrid
• For PhD candidates and early-career researchers
• A notice will be published soon on the Leiden University website. For now, see more information on the Una Europa website: https://www.una-europa.eu/calendar/una-europa-challenge-data-science-and-ai-for-social-welfare-2026
• Deadline: April 17

Call for proposals for Horizon funding focused on digital health and AI in sub-Saharan Africa.

• The deadline for this call is 2 September 2026.
• More information can be found via the EU Funding & Tenders Portal.

 

Call for evidence on the upcoming European Commission Global Health Resilience Initiative (GHRI)

• The consultation is open for feedback until 13 April 2026.
• Attached is a longer strategy document by CEPI highlighting some of the key issues they feel need to be addressed that fit the remit of this initiative.
• As a reminder, this was launched by EU President von der Leyen and therefore is expected to get strong political backing once agreed.
• The more (separate) inputs the better so have a go and feel free to use any of the CEPI suggestions you may find aligned with yours! Repetition and similar messages is MUCH better than originality here given the expected inputs !
• In short and aligned with the Dutch Hub priorities, CEPI is calling for a focus on:

• • health R&D systems capacity complementing large investments in health systems like Global Fund, World Bank who, often by design, exclude MCM countermeasure work ahead of regulatory approval
  • 100DM readiness testing (ranging from tabletop exercises, to live fire drills)
  • Manufacturing, manufacturing innovation and tech transfer – ensuring to stress the importance to continue and expand the MAV+ program (the current ODA global health focus of the European Commission)
  • And reviewing and optimising the financial instruments we have for the next MFF (esp blended finance tools with EIB)
  • It also addresses the Global Health Architecture work, with a note that R&D and readiness is essentially a multilateral activity as the threats are regional or global AND you can’t do MCM product development in a single country or often even region. In other words: back global initiatives for R&D as they cannot be bilateral